NGHLF (Nightingale Health) Current Deferred Revenue: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGHLF Nightingale Health PLC NGHLF
67 GF Score
Price $1.19
GF Value $4.61
! 6 Warning Signs
View Full Analysis

What is Nightingale Health Current Deferred Revenue?

Nightingale Health NGHLF 67 Current Deferred Revenue is $0.00 Mil as of Dec. 2025. GuruFocus rates NGHLF with a GF Score™ of 67/100 and a GF Value™ of $4.61. The stock has 6 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Nightingale Health's current deferred revenue for the quarter that ended in Dec. 2025 was $0.00 Mil.

Nightingale Health Current Deferred Revenue Related Terms

Nightingale Health Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Nightingale Health's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nightingale Health Current Deferred Revenue Chart

Nightingale Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nightingale Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NGHLF
67GF Score
Nightingale Health PLC NGHLF
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.00 Mil mean?
Nightingale Health (NGHLF) has a Current Deferred Revenue of $0.00 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Nightingale Health and its competitors.
Is Nightingale Health's Current Deferred Revenue too high?
Nightingale Health's current Current Deferred Revenue is $0.00 Mil. Overall, Nightingale Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's Current Deferred Revenue compare to VEEV and BTSG?
Nightingale Health's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Nightingale Health and its competitors. Nightingale Health's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Nightingale Health (NGHLF) has a current Current Deferred Revenue of $0.00 Mil. The stock's GF Value™ is $4.61, compared to a current price of $1.19 — trading 74.2% below its estimated fair value. The current Current Deferred Revenue is $0.00 Mil. Nightingale Health's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current Current Deferred Revenue is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nightingale Health (NGHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of $1.19 is trading 74.2% below its estimated GF Value™ of $4.61.

Key valuation signals for NGHLF:

  • Current Deferred Revenue: $0.00 Mil
  • GF Value™: $4.61 vs. price of $1.19 (74.2% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nightingale Health Business Description

Other Exchanges HEALTH:Finland7XE:Germany
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
67GF Score

Get the complete analysis for NGHLF

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$4.61
GF Value